These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Acylation of the Incretin Peptide Exendin-4 Directly Impacts Glucagon-Like Peptide-1 Receptor Signaling and Trafficking. Lucey M; Ashik T; Marzook A; Wang Y; Goulding J; Oishi A; Broichhagen J; Hodson DJ; Minnion J; Elani Y; Jockers R; Briddon SJ; Bloom SR; Tomas A; Jones B Mol Pharmacol; 2021 Oct; 100(4):319-334. PubMed ID: 34315812 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of efficacy- versus affinity-driven agonism with biased GLP-1R ligands P5 and exendin-F1. Marzook A; Chen S; Pickford P; Lucey M; Wang Y; Corrêa IR; Broichhagen J; Hodson DJ; Salem V; Rutter GA; Tan TM; Bloom SR; Tomas A; Jones B Biochem Pharmacol; 2021 Aug; 190():114656. PubMed ID: 34129856 [TBL] [Abstract][Full Text] [Related]
5. A Targeted RNAi Screen Identifies Endocytic Trafficking Factors That Control GLP-1 Receptor Signaling in Pancreatic β-Cells. Buenaventura T; Kanda N; Douzenis PC; Jones B; Bloom SR; Chabosseau P; Corrêa IR; Bosco D; Piemonti L; Marchetti P; Johnson PR; Shapiro AMJ; Rutter GA; Tomas A Diabetes; 2018 Mar; 67(3):385-399. PubMed ID: 29284659 [TBL] [Abstract][Full Text] [Related]
7. Targeting GLP-1 receptor trafficking to improve agonist efficacy. Jones B; Buenaventura T; Kanda N; Chabosseau P; Owen BM; Scott R; Goldin R; Angkathunyakul N; Corrêa IR; Bosco D; Johnson PR; Piemonti L; Marchetti P; Shapiro AMJ; Cochran BJ; Hanyaloglu AC; Inoue A; Tan T; Rutter GA; Tomas A; Bloom SR Nat Commun; 2018 Apr; 9(1):1602. PubMed ID: 29686402 [TBL] [Abstract][Full Text] [Related]
8. The Interplay of Glucagon-Like Peptide-1 Receptor Trafficking and Signalling in Pancreatic Beta Cells. Marzook A; Tomas A; Jones B Front Endocrinol (Lausanne); 2021; 12():678055. PubMed ID: 34040588 [TBL] [Abstract][Full Text] [Related]
9. Agonist-induced internalisation of the glucagon-like peptide-1 receptor is mediated by the Gαq pathway. Thompson A; Kanamarlapudi V Biochem Pharmacol; 2015 Jan; 93(1):72-84. PubMed ID: 25449603 [TBL] [Abstract][Full Text] [Related]
14. Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice. Lamont BJ; Li Y; Kwan E; Brown TJ; Gaisano H; Drucker DJ J Clin Invest; 2012 Jan; 122(1):388-402. PubMed ID: 22182839 [TBL] [Abstract][Full Text] [Related]
16. Pancreatic alpha cells in diabetic rats express active GLP-1 receptor: Endosomal co-localization of GLP-1/GLP-1R complex functioning through intra-islet paracrine mechanism. Nakashima K; Kaneto H; Shimoda M; Kimura T; Kaku K Sci Rep; 2018 Feb; 8(1):3725. PubMed ID: 29487355 [TBL] [Abstract][Full Text] [Related]
17. Computational modelling of dynamic cAMP responses to GPCR agonists for exploration of GLP-1R ligand effects in pancreatic β-cells and neurons. Bridge L; Chen S; Jones B Cell Signal; 2024 Jul; 119():111153. PubMed ID: 38556030 [TBL] [Abstract][Full Text] [Related]
18. Progesterone receptor membrane component 1 is a functional part of the glucagon-like peptide-1 (GLP-1) receptor complex in pancreatic β cells. Zhang M; Robitaille M; Showalter AD; Huang X; Liu Y; Bhattacharjee A; Willard FS; Han J; Froese S; Wei L; Gaisano HY; Angers S; Sloop KW; Dai FF; Wheeler MB Mol Cell Proteomics; 2014 Nov; 13(11):3049-62. PubMed ID: 25044020 [TBL] [Abstract][Full Text] [Related]
19. The glucagon-like peptide-1 receptor agonist oxyntomodulin enhances beta-cell function but does not inhibit gastric emptying in mice. Maida A; Lovshin JA; Baggio LL; Drucker DJ Endocrinology; 2008 Nov; 149(11):5670-8. PubMed ID: 18669601 [TBL] [Abstract][Full Text] [Related]